# Citicoline
*Source: https://go.drugbank.com/drugs/DB12153*

## Overview

### Description

This compound belongs to the class of organic compounds known as pyrimidine ribonucleoside diphosphates. These are pyrimidine ribonucleotides with diphosphate group  linked to the ribose moiety.

### Background

Citicoline is a donor of choline in biosynthesis of choline-containing phosphoglycerides. It has been investigated for the treatment, supportive care, and diagnosis of Mania, Stroke, Hypomania, Cocaine Abuse, and Bipolar Disorder, among others.

### Drug Interactions

This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available

## Chemical Information

**Synonyms:** CDP-choline
CDP-colina
citicolina
Citicoline
citidin difosfato de colina
Cytidine 5'-(choline diphosphate)
Cytidine 5'-(cholinyl pyrophosphate)
Cytidine 5'-diphosphocholine
Cytidine 5'-diphosphoric choline
Cytidine-5'-diphosphocholine

**Chemical Formula:** C
14
H
26
N
4
O
11
P
2

**SMILES:** C[N+](C)(C)CCOP([O-])(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=CC(N)=NC1=O

**Weight:** Average: 488.324
Monoisotopic: 488.107330718

**IUPAC Name:** {2-[({[(2R,3S,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl phosphono)oxy]ethyl}trimethylazanium

## Additional Information

### Summary

Citicoline
is an endogenous intermediate in the formation of phosphatidylcholine from choline which is thought to have neuroprotective effects.

### Generic Name

Citicoline

### DrugBank Accession Number

DB12153

### Modality

Small Molecule

### Groups

Approved, Investigational, Withdrawn

### Structure

3D
Download
MOL
SDF
3D-SDF
PDB
SMILES
InChI
Similar Structures
Structure for Citicoline (DB12153)
×
Close

### Associated Conditions

Indication Type
Indication
Combined Product Details
Approval Level
Age Group
Patient Characteristics
Dose Form
Management of
Degenerative brain disorder
••••••••••••
Create Account
Management of
Parkinsonian syndromes
••••••••••••
Create Account
•••••••••• •••••••••• ••••••••
Create Account

### Mechanism of action

Target
Actions
Organism
U
LicC protein
Not Available
Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)

### Product Ingredients

Ingredient
UNII
CAS
InChI Key
Citicoline sodium
7XQ5AKD9YD
33818-15-4
YWAFNFGRBBBSPD-OCMLZEEQSA-M

### ATC Codes

N06BX06 — Citicoline
N06BX — Other psychostimulants and nootropics
N06B — PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS
N06 — PSYCHOANALEPTICS
N — NERVOUS SYSTEM

### Drug Categories

Amines
Central Nervous System Agents
Cytidine Diphosphate
Cytosine Nucleotides
Nervous System
Nootropic Agents
Nucleic Acids, Nucleotides, and Nucleosides
Nucleotides
Onium Compounds
Psychoanaleptics
Psychostimulants, Agents Used for ADHD and Nootropics
Pyrimidine Nucleotides
Pyrimidines
Quaternary Ammonium Compounds
Ribonucleotides
Trimethyl Ammonium Compounds

### Chemical TaxonomyProvided byClassyfire

Description
This compound belongs to the class of organic compounds known as pyrimidine ribonucleoside diphosphates. These are pyrimidine ribonucleotides with diphosphate group  linked to the ribose moiety.
Kingdom
Organic compounds
Super Class
Nucleosides, nucleotides, and analogues
Class
Pyrimidine nucleotides
Sub Class
Pyrimidine ribonucleotides
Direct Parent
Pyrimidine ribonucleoside diphosphates
Alternative Parents
Pentose phosphates
/
Glycosylamines
/
Phosphocholines
/
Monosaccharide phosphates
/
Organic pyrophosphates
/
Pyrimidones
/
Aminopyrimidines and derivatives
/
Monoalkyl phosphates
/
Hydropyrimidines
/
Imidolactams
/
Tetraalkylammonium salts
/
Tetrahydrofurans
/
Heteroaromatic compounds
/
Secondary alcohols
/
1,2-diols
/
Oxacyclic compounds
/
Azacyclic compounds
/
Organic salts
/
Organic zwitterions
/
Hydrocarbon derivatives
/
Organopnictogen compounds
/
Organic oxides
/
Primary amines
show 13 more
Substituents
1,2-diol
/
Alcohol
/
Alkyl phosphate
/
Amine
/
Aminopyrimidine
/
Aromatic heteromonocyclic compound
/
Azacycle
/
Glycosyl compound
/
Heteroaromatic compound
/
Hydrocarbon derivative
/
Hydropyrimidine
/
Imidolactam
/
Monoalkyl phosphate
/
Monosaccharide
/
Monosaccharide phosphate
/
N-glycosyl compound
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organic phosphoric acid derivative
/
Organic pyrophosphate
/
Organic salt
/
Organic zwitterion
/
Organoheterocyclic compound
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Oxacycle
/
Pentose monosaccharide
/
Pentose phosphate
/
Pentose-5-phosphate
/
Phosphocholine
/
Phosphoric acid ester
/
Primary amine
/
Pyrimidine
/
Pyrimidine ribonucleoside diphosphate
/
Pyrimidone
/
Quaternary ammonium salt
/
Secondary alcohol
/
Tetraalkylammonium salt
/
Tetrahydrofuran
show 31 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
phosphocholines, nucleotide-(amino alcohol)s (
CHEBI:16436
)

### Kingdom

Organic compounds

### Super Class

Nucleosides, nucleotides, and analogues

### Class

Pyrimidine nucleotides

### Sub Class

Pyrimidine ribonucleotides

### Direct Parent

Pyrimidine ribonucleoside diphosphates

### Alternative Parents

Pentose phosphates
/
Glycosylamines
/
Phosphocholines
/
Monosaccharide phosphates
/
Organic pyrophosphates
/
Pyrimidones
/
Aminopyrimidines and derivatives
/
Monoalkyl phosphates
/
Hydropyrimidines
/
Imidolactams
/
Tetraalkylammonium salts
/
Tetrahydrofurans
/
Heteroaromatic compounds
/
Secondary alcohols
/
1,2-diols
/
Oxacyclic compounds
/
Azacyclic compounds
/
Organic salts
/
Organic zwitterions
/
Hydrocarbon derivatives
/
Organopnictogen compounds
/
Organic oxides
/
Primary amines
show 13 more

### Substituents

1,2-diol
/
Alcohol
/
Alkyl phosphate
/
Amine
/
Aminopyrimidine
/
Aromatic heteromonocyclic compound
/
Azacycle
/
Glycosyl compound
/
Heteroaromatic compound
/
Hydrocarbon derivative
/
Hydropyrimidine
/
Imidolactam
/
Monoalkyl phosphate
/
Monosaccharide
/
Monosaccharide phosphate
/
N-glycosyl compound
/
Organic nitrogen compound
/
Organic oxide
/
Organic oxygen compound
/
Organic phosphoric acid derivative
/
Organic pyrophosphate
/
Organic salt
/
Organic zwitterion
/
Organoheterocyclic compound
/
Organonitrogen compound
/
Organooxygen compound
/
Organopnictogen compound
/
Oxacycle
/
Pentose monosaccharide
/
Pentose phosphate
/
Pentose-5-phosphate
/
Phosphocholine
/
Phosphoric acid ester
/
Primary amine
/
Pyrimidine
/
Pyrimidine ribonucleoside diphosphate
/
Pyrimidone
/
Quaternary ammonium salt
/
Secondary alcohol
/
Tetraalkylammonium salt
/
Tetrahydrofuran
show 31 more

### Molecular Framework

Aromatic heteromonocyclic compounds

### External Descriptors

phosphocholines, nucleotide-(amino alcohol)s (
CHEBI:16436
)

### UNII

536BQ2JVC7

### CAS number

987-78-0

### InChI Key

RZZPDXZPRHQOCG-OJAKKHQRSA-N

### InChI

InChI=1S/C14H26N4O11P2/c1-18(2,3)6-7-26-30(22,23)29-31(24,25)27-8-9-11(19)12(20)13(28-9)17-5-4-10(15)16-14(17)21/h4-5,9,11-13,19-20H,6-8H2,1-3H3,(H3-,15,16,21,22,23,24,25)/t9-,11-,12-,13-/m1/s1

### General References

AIFA Product Information: Difosfocin (citicoline) solution for injection [
Link
]
INVIMA Product Information: Complegel NF (citicoline) coated tablets [
Link
]

### External Links

Human Metabolome Database
HMDB0001413
KEGG Drug
D00057
KEGG Compound
C00307
PubChem Substance
347911290
ChemSpider
13207
RxNav
997602
ChEBI
16436
ChEMBL
CHEMBL1231700
PDBe Ligand
CDC
Wikipedia
Citicoline

### Human Metabolome Database

HMDB0001413

### KEGG Drug

D00057

### KEGG Compound

C00307

### PubChem Substance

347911290

### ChemSpider

13207

### RxNav

997602

### ChEBI

16436

### ChEMBL

CHEMBL1231700

### PDBe Ligand

CDC

### Wikipedia

Citicoline

### PDB Entries

1jyl
/
3hl4
/
4bet
/
4mvc
/
4mvd
/
4zcs
/
8erp
/
8gyw
/
8urp

### Dosage Forms

Form
Route
Strength
Injection, solution
Parenteral
500 MG/3ML
Injection
Intramuscular; Intravenous
1000 mg/4ml
Injection
Intramuscular; Intravenous
500 mg/4ml
Injection, solution
Intramuscular; Intravenous
1045 MG
Injection, solution
Intramuscular; Intravenous
522.5 MG
Tablet
Oral
522.500 mg
Injection, solution
Parenteral
1 G/5ML
Injection
Intramuscular; Intravenous
130.63 mg
Injection, solution
Parenteral
1000 MG/5ML
Injection, solution
Intramuscular; Intravenous
0.1 g/2ml
Injection, solution
Intramuscular; Intravenous
1 g/4ml
Injection, solution
Intramuscular; Intravenous
250 mg/2ml
Injection, solution
Intramuscular; Intravenous
500 mg/4ml
Injection, solution
Intramuscular; Intravenous; Intravenous drip
100 mg
Injection, solution
Intramuscular; Intravenous; Intravenous drip
1000 mg
Injection, solution
Intramuscular
Injection
Intramuscular; Intravenous
125 mg/ml
Injection, solution
Intramuscular; Intravenous
1000 mg/4ml
Solution
Oral
1 g
Injection
Intramuscular; Intravenous
125 mg
Tablet
Oral
522.6 mg
Tablet, film coated
Oral
250 mg
Injection, solution
Intramuscular; Intravenous
1000 mg
Tablet
Oral
522.506 mg
Injection
Intramuscular; Intravenous
100 mg
Injection
Intramuscular; Intravenous
1000 mg
Injection
Intramuscular; Intravenous
250 mg
Injection
Intramuscular; Intravenous
500 mg
Injection
Intramuscular; Intravenous
522.537 mg
Injection
Intramuscular; Intravenous
Injection, solution
Parenteral
100 MG/2ML
Injection, solution
Parenteral
1000 MG/4ML
Injection, solution
Parenteral
250 MG/2ML
Injection, solution
Parenteral
500 MG/4ML
Injection
Intramuscular; Intravenous
250 MG/2ML
Solution
Parenteral
500.000 mg
Solution
Parenteral
1045.020 mg
Solution
Oral
1000.000 mg
Injection, solution
Parenteral
1 G/4ML
Solution
Intravenous
1000.000 mg
Tablet
Oral
500 mg
Tablet, coated
Oral
500 mg
Injection, solution
Intramuscular; Intravenous
500 mg
Tablet, coated
Oral
50000000 mg
Injection, solution
Intramuscular; Intravenous
125 mg/ml
Solution
Oral
1000 MG
Solution
Intravenous
500.000 mg
Solution
Oral
10.45 g
Solution
Intravenous
1047.155 mg
Tablet
Oral
500.000 mg
Solution
Oral
1000 mg/4ml

### Predicted Properties

Property
Value
Source
Water Solubility
7.99 mg/mL
ALOGPS
logP
-1.4
ALOGPS
logP
-7.1
Chemaxon
logS
-1.8
ALOGPS
pKa (Strongest Acidic)
1.84
Chemaxon
pKa (Strongest Basic)
-2.6
Chemaxon
Physiological Charge
-1
Chemaxon
Hydrogen Acceptor Count
10
Chemaxon
Hydrogen Donor Count
4
Chemaxon
Polar Surface Area
213.5 Å
2
Chemaxon
Rotatable Bond Count
10
Chemaxon
Refractivity
113.58 m
3
·mol
-1
Chemaxon
Polarizability
42.54 Å
3
Chemaxon
Number of Rings
2
Chemaxon
Bioavailability
1
Chemaxon
Rule of Five
Yes
Chemaxon
Ghose Filter
No
Chemaxon
Veber's Rule
No
Chemaxon
MDDR-like Rule
No
Chemaxon

### Predicted ADMET Features

Property
Value
Probability
Human Intestinal Absorption
-
0.9964
Blood Brain Barrier
-
0.626
Caco-2 permeable
-
0.6489
P-glycoprotein substrate
Substrate
0.6427
P-glycoprotein inhibitor I
Non-inhibitor
0.9504
P-glycoprotein inhibitor II
Non-inhibitor
0.9873
Renal organic cation transporter
Non-inhibitor
0.9328
CYP450 2C9 substrate
Non-substrate
0.7797
CYP450 2D6 substrate
Non-substrate
0.8109
CYP450 3A4 substrate
Substrate
0.6171
CYP450 1A2 substrate
Non-inhibitor
0.8289
CYP450 2C9 inhibitor
Non-inhibitor
0.8439
CYP450 2D6 inhibitor
Non-inhibitor
0.8274
CYP450 2C19 inhibitor
Non-inhibitor
0.8009
CYP450 3A4 inhibitor
Non-inhibitor
0.8877
CYP450 inhibitory promiscuity
Low CYP Inhibitory Promiscuity
0.9675
Ames test
Non AMES toxic
0.6538
Carcinogenicity
Non-carcinogens
0.8806
Biodegradation
Ready biodegradable
0.7564
Rat acute toxicity
1.6863 LD50, mol/kg
Not applicable
hERG inhibition (predictor I)
Weak inhibitor
0.9031
hERG inhibition (predictor II)
Non-inhibitor
0.6674
ADMET data is predicted using
admetSAR
, a free tool for evaluating chemical ADMET properties. (
23092397
)

### Spectra

Spectrum
Spectrum Type
Splash Key
Predicted GC-MS Spectrum - GC-MS
Predicted GC-MS
splash10-00fr-7649200000-859d046834f1fbd3d535
MS/MS Spectrum - Quattro_QQQ 10V, Positive
LC-MS/MS
splash10-0006-0001900000-a9f38ff6b185b45f04b3
MS/MS Spectrum - Quattro_QQQ 25V, Positive
LC-MS/MS
splash10-03e9-0590000000-b021677d064d65810ee0
MS/MS Spectrum - Quattro_QQQ 40V, Positive
LC-MS/MS
splash10-001i-0900000000-7570bbb10dd9fa288442
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive
LC-MS/MS
splash10-000i-0000900000-8b411373962b073b4d22
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) 30V, Positive
LC-MS/MS
splash10-000i-0001900000-6e7cc437ad79eb13c032
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Positive
LC-MS/MS
splash10-01qi-1932200000-9c3803cefdd9c6285a7c
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative
LC-MS/MS
splash10-004i-6505900000-3d534aab6e40915c3642
LC-MS/MS Spectrum - LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) , Negative
LC-MS/MS
splash10-004i-6505900000-fc13e5ad403e7faf8218
LC-MS/MS Spectrum - LC-ESI-QTOF , negative
LC-MS/MS
splash10-004i-6505900000-3d534aab6e40915c3642
LC-MS/MS Spectrum - LC-ESI-QTOF , negative
LC-MS/MS
splash10-004i-6505900000-fc13e5ad403e7faf8218
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-000i-0000900000-8b411373962b073b4d22
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-000i-0001900000-6e7cc437ad79eb13c032
LC-MS/MS Spectrum - LC-ESI-QTOF , positive
LC-MS/MS
splash10-01qi-1932200000-4a7ae92c6e127d2ce453
1H NMR Spectrum
1D NMR
Not Applicable
Predicted 1H NMR Spectrum
1D NMR
Not Applicable
Predicted 13C NMR Spectrum
1D NMR
Not Applicable
[1H,13C] 2D NMR Spectrum
2D NMR
Not Applicable

### Chromatographic Properties

Collision Cross Sections (CCS)
Adduct
CCS Value (Å
2
)
Source type
Source
[M-H]-
235.1178185
predicted
DarkChem Lite v0.1.0
[M-H]-
228.3908185
predicted
DarkChem Lite v0.1.0
[M-H]-
186.6222
predicted
DeepCCS 1.0 (2019)
[M+H]+
236.3929185
predicted
DarkChem Lite v0.1.0
[M+H]+
229.6900185
predicted
DarkChem Lite v0.1.0
[M+H]+
188.5176
predicted
DeepCCS 1.0 (2019)
[M+Na]+
235.3875185
predicted
DarkChem Lite v0.1.0
[M+Na]+
229.0222185
predicted
DarkChem Lite v0.1.0
[M+Na]+
194.3821
predicted
DeepCCS 1.0 (2019)

### Kind

Protein

### Organism

Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4)

### Pharmacological action

Unknown

### Specific Function

metal ion binding

### Gene Name

licC

### Uniprot ID

A0A0H2UQB5

### Uniprot Name

LicC protein

### Molecular Weight

26903.28 Da

